ArticleTranslational oncology2026

NTRK2 promotes malignant progression and paclitaxel resistance of lung adenocarcinoma through targeting MYC/ABCF1 axis.

Rongrong Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.